Fractyl Health, Inc.
GUTS
$1.50
-$0.13-7.98%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -7.75% | -34.50% | -418.63% | 82.68% | -21.80% |
Total Depreciation and Amortization | 6.70% | 8.85% | 262.26% | 39.47% | -54.76% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -98.24% |
Total Other Non-Cash Items | -1.66% | 474.39% | 93.75% | -262.12% | 141.36% |
Change in Net Operating Assets | 132.00% | 324.11% | -128.00% | 187.32% | 471.03% |
Cash from Operations | 5.57% | 3.73% | -59.99% | -10.49% | 3.80% |
Capital Expenditure | -9.39% | 18.08% | 75.45% | -678.68% | 8.11% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -9.39% | 18.08% | 75.45% | -678.68% | 8.11% |
Total Debt Issued | -- | -- | -- | -- | -100.00% |
Total Debt Repaid | -82.76% | -176.19% | -950.00% | 33.33% | 96.10% |
Issuance of Common Stock | -21.36% | 1,275.00% | -99.98% | 610,829.41% | 240.00% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | 100.00% | -400.70% | -45.04% |
Cash from Financing | -58.64% | 3,340.00% | -100.00% | 18,265.83% | -101.99% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 4.92% | 4.80% | -121.54% | 881.44% | -167.20% |